1. Home
  2. TFII vs RGEN Comparison

TFII vs RGEN Comparison

Compare TFII & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFI International Inc.

TFII

TFI International Inc.

HOLD

Current Price

$99.63

Market Cap

7.4B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.07

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFII
RGEN
Founded
1957
1981
Country
Canada
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TFII
RGEN
Price
$99.63
$162.07
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$112.20
$170.90
AVG Volume (30 Days)
271.4K
797.9K
Earning Date
10-30-2025
10-28-2025
Dividend Yield
1.84%
N/A
EPS Growth
N/A
N/A
EPS
3.89
0.03
Revenue
$8,047,566,000.00
$707,890,000.00
Revenue This Year
N/A
$17.84
Revenue Next Year
$2.77
$12.57
P/E Ratio
$25.36
$6,320.44
Revenue Growth
N/A
11.74
52 Week Low
$72.02
$102.97
52 Week High
$155.12
$182.52

Technical Indicators

Market Signals
Indicator
TFII
RGEN
Relative Strength Index (RSI) 69.01 52.39
Support Level $86.94 $160.11
Resistance Level $100.40 $170.40
Average True Range (ATR) 2.64 5.46
MACD 1.75 -0.76
Stochastic Oscillator 91.71 44.17

Price Performance

Historical Comparison
TFII
RGEN

About TFII TFI International Inc.

TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: